Stay updated with breaking news from Progression Scale. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Antibiotic treatment of adults hospitalized with moderate COVID-19 is associated with clinical deterioration, despite the drugs being given to over 40% of patients, according to new research being presented at this year's ESCMID Global Congress (formerly ECCMID) in Barcelona, Spain (27-30 April)
This platform randomized clinical trial examines the effectiveness ivermectin at a targeted dose of 600 μg/kg daily compared with placebo for the treatment of e
Compared with placebo, convalescent plasma with neutralizinganti-SARS-CoV-2 antibodies showed no improvement in hospitalized patients with COVID-19 at day 14, according to a study published in CHEST.
Researchers assessed the impact of ivermectin on the duration of sustained recovery among coronavirus disease 2019 (COVID-19) outpatients.
This randomized clinical trial compares the efficacy of ivermectin vs placebo in shortening symptom duration among adult outpatients in the US with symptomatic